Sun Pharma's future brightens considerably with FDA plant upgrade and China drug deal

After five years of struggles, Sun Pharmaceutical has put the problems at its key plant in Halol, India, behind it. The FDA has indicated Sun’s improvements have reached a point where it sees no further changes from the drugmaker are required.